Janssen drops US lawsuit against Samsung Bioepis Remicade copy Ruby Khatun Khatun16 Nov 2017 9:15 AM ISTSEOUL: A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug...
FDA approves first drug in US with digital ingestion tracking Ruby Khatun Khatun15 Nov 2017 10:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole...
Bill Gates makes 100 million dollars personal investment to fight Alzheimer Ruby Khatun Khatun15 Nov 2017 10:25 AM ISTLONDON: Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings...
Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore Ruby Khatun Khatun15 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
Novartis launches heart drug counter-offensive Ruby Khatun Khatun15 Nov 2017 9:45 AM ISTZURICH: Novartis plans to plow through doubts over its canakinumab drug by asking regulators this year to approve the medicine as a treatment for a...
Apollo Hospitals Q2 net dips 23 percent to Rs 71 crore Ruby Khatun Khatun15 Nov 2017 9:26 AM ISTNew Delhi: Apollo Hospitals Enterprise reported 22.92 percent dip in standalone net profit to Rs 70.90 crore for the September quarter of the current...
CureFit to expand to Delhi-NCR, invest Rs 25 crore Ruby Khatun Khatun14 Nov 2017 10:37 AM ISTNew Delhi: Health-technology startup CureFit will invest about Rs 25 crore to expand its operations to Delhi-NCR and set up 30 'Cult' premium fitness...
Morepen Labs reports 24 percent jump in its Q2 net profit Ruby Khatun Khatun14 Nov 2017 10:16 AM ISTNew Delhi: Morepen Laboratories Ltd. has reported a stable set of numbers in the second quarter (Q2) of fiscal 2017-18. The company has registered a...
Pfizer Q2 net dips 12 percent at Rs 111.15 crore Ruby Khatun Khatun14 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Pfizer reported a 12 percent dip in standalone net profit to Rs 111.15 crore for the quarter ended September 30, 2017.The company...
Novartis posts eye drug data amid play for Eylea's turf Ruby Khatun Khatun14 Nov 2017 9:45 AM ISTZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
Suven Life Sciences Q2 net up 20 percent to Rs 32 crore Ruby Khatun Khatun14 Nov 2017 9:23 AM ISTNew Delhi: Suven Life Sciences reported a 19.5 percent increase in net profit to Rs 31.74 crore for the second quarter ended September 30.The company...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 10:02 AM ISTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
